These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37657474)

  • 1. Incorporating absolute effects to enrich interpretation of findings from meta-analyses - Authors' reply.
    Petit C; Pignon JP; Blanchard P
    Lancet Oncol; 2023 Sep; 24(9):e359. PubMed ID: 37657474
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporating absolute effects to enrich interpretation of findings from meta-analyses.
    Wu J; Xie S; He X; Hong T; Yao L
    Lancet Oncol; 2023 Sep; 24(9):e358. PubMed ID: 37657473
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to: Practical methods for incorporating summary time-to-event data into meta. Authors' reply.
    Tierney JF; Stewart LA; Ghersi D; Burdett S; Sydes MR
    Trials; 2013; 14():391. PubMed ID: 24511621
    [No Abstract]   [Full Text] [Related]  

  • 4. Network meta-analyses and treatment recommendations for obsessive-compulsive disorder - Authors' reply.
    Skapinakis P; Caldwell DM; Hollingworth W; Welton NJ; Fineberg N; Salkovskis P; Churchill R; Lewis G
    Lancet Psychiatry; 2016 Oct; 3(10):921-922. PubMed ID: 27692264
    [No Abstract]   [Full Text] [Related]  

  • 5. Authors' reply on Cochrane reviews v industry supported meta-analyses.
    Jørgensen AW; Gøtzsche PC; Hilden J
    BMJ; 2006 Nov; 333(7577):1072-3. PubMed ID: 17120335
    [No Abstract]   [Full Text] [Related]  

  • 6. Accurately addressing double-arm-zero-events studies in meta-analyses - Authors' reply.
    Fujiwara Y; Horita N; Naqash AR
    Lancet Oncol; 2024 Mar; 25(3):e93. PubMed ID: 38423061
    [No Abstract]   [Full Text] [Related]  

  • 7. Real-life implications of prevalence meta-analyses? Doi plots and prediction intervals are the answer - Authors' reply.
    Soucy JR; Langford BJ; So M; Raybardhan S; MacFadden D; Daneman N; Bertagnolio S
    Lancet Microbe; 2023 Jul; 4(7):e491. PubMed ID: 37116519
    [No Abstract]   [Full Text] [Related]  

  • 8. Further clinical interpretation and implications of KEYNOTE-048 findings - Authors' reply.
    Burtness B; Zhang Y; Harrington KJ; Rischin D
    Lancet; 2020 Aug; 396(10248):379-380. PubMed ID: 32771104
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: coffee consumption and gallstone disease - a cautionary note on the assignment of exposure values in dose-response meta-analyses. Authors' reply.
    Zhang YP; Li WQ; Sun YL; Zhu RT; Wang WJ
    Aliment Pharmacol Ther; 2016 Jan; 43(1):167-8. PubMed ID: 26638933
    [No Abstract]   [Full Text] [Related]  

  • 10. Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.
    Meinel AB; Meinel MP
    Appl Opt; 1985 Apr; 24(7):944. PubMed ID: 20436652
    [No Abstract]   [Full Text] [Related]  

  • 11. Authors' Reply to Kahlaee et al: "A Systematic Review and Meta-Analyses of the Association Between Anti-hypertensive Classes and the Risk of Falls Among Older Adults".
    Lim KK; Ang HT; Kwan YH; Tan CS; Ostbye T; Low LL
    Drugs Aging; 2019 Jan; 36(1):95-101. PubMed ID: 30421390
    [No Abstract]   [Full Text] [Related]  

  • 12. Authors' reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2 diabetes and cancer.
    Tsilidis KK; Ioannidis JP
    BMJ; 2015 Feb; 350():h711. PubMed ID: 25673332
    [No Abstract]   [Full Text] [Related]  

  • 13. Network meta-analysis of antidepressants - Authors' reply.
    Cipriani A; Salanti G; Furukawa TA; Turner E; Ioannidis JPA; Geddes JR
    Lancet; 2018 Sep; 392(10152):1012-1013. PubMed ID: 30264703
    [No Abstract]   [Full Text] [Related]  

  • 14. No space for all-or-nothing in epidemiology: The art of parsimony and interpretation - Authors' reply.
    Tardelli VS; Bianco MCM; Prakash R; Segura LE; Castaldelli-Maia JM; Fidalgo TM; Martins SS
    Lancet Reg Health Am; 2022 Jun; 10():100288. PubMed ID: 36777684
    [No Abstract]   [Full Text] [Related]  

  • 15. Interpretation of results of pooled analysis of individual patient data - Authors' reply.
    Head SJ; Papageorgiou G; Milojevic M; Stone GW; Kappetein AP
    Lancet; 2018 Sep; 392(10150):818. PubMed ID: 30215376
    [No Abstract]   [Full Text] [Related]  

  • 16. Authors' Reply: Efficacy and Safety of Non-operative Management of Uncomplicated Acute Appendicitis Compared to Appendectomy: An Umbrella Review of Systematic Reviews and Meta-analyses.
    Emile SH; Elfeki H
    World J Surg; 2022 Aug; 46(8):2010-2011. PubMed ID: 35637353
    [No Abstract]   [Full Text] [Related]  

  • 17. Ranking treatments in the network meta-analysis should consider the certainty of evidence - Authors' reply.
    Lasa JS; Olivera PA; Peyrin-Biroulet L
    Lancet Gastroenterol Hepatol; 2022 Apr; 7(4):288. PubMed ID: 35278398
    [No Abstract]   [Full Text] [Related]  

  • 18. Absolute and relative declines in child mortality in India's districts during 2001-12--authors' reply.
    Ram U; Jha P; Ram F; Kumar R
    Lancet Glob Health; 2014 Jan; 2(1):e21. PubMed ID: 25104630
    [No Abstract]   [Full Text] [Related]  

  • 19. Authors' Reply to Letter to the Editor Regarding the Article "Risk and Influencing Factors for Subsequent Primary Lung Cancer After Treatment of Breast Cancer: A Systematic Review and Two Meta-Analyses Based on Four Million Cases".
    Wang Y; Che G
    J Thorac Oncol; 2023 Apr; 18(4):e46-e47. PubMed ID: 36990581
    [No Abstract]   [Full Text] [Related]  

  • 20. Confidence of evidence should be considered in ranking of treatments in the network meta-analysis - Authors' reply.
    Bighelli I; Rodolico A; Siafis S; Leucht S
    Lancet Psychiatry; 2022 Apr; 9(4):e16. PubMed ID: 35305750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.